Obama Proposes Drug-Price Curbing Measures, Medicare Advantage Bid Program

The president's 2017 budget proposes a handful of major new CMS policies, including several aimed at reducing drug prices. The budget calls for letting CMS partner with states to negotiate down drug prices, making drug makers disclose discounts and research-and-development costs, requiring drug wholesalers to report wholesale acquisition costs, requiriing evidence development for Part D drugs, creating a Medicare Advantage bidding program, eliminating surprise out-of-network charges in commercial plans, and giving Puerto Rico and other territories $30 billion more in...